The present invention generally relates to medical systems and apparatus and uses thereof for treating obesity and/or obesity-related diseases, and more specifically, relates to access ports and tools for applying same to bodily tissue.
Adjustable gastric banding apparatus have provided an effective and substantially less invasive alternative to gastric bypass surgery and other conventional surgical weight loss procedures. Despite the positive outcomes of invasive weight loss procedures, such as gastric bypass surgery, it has been recognized that sustained weight loss can be achieved through a laparoscopically-placed gastric band, for example, the LAP-BAND® (Allergan, Inc., Irvine, Calif.) gastric band or the LAP-BAND AP® (Allergan, Inc., Irvine, Calif.) gastric band. Generally, gastric bands are placed about the cardia, or upper portion, of a patient's stomach forming a stoma that restricts food's passage into a lower portion of the stomach. When the stoma is of an appropriate size that is restricted by a gastric band, food held in the upper portion of the stomach provides a feeling of satiety or fullness that discourages overeating. Unlike gastric bypass procedures, gastric band apparatus are reversible and require no permanent modification to the gastrointestinal tract.
Medical implants, including gastric band systems, for performing therapeutic functions for a patient are well known. Such devices include pace makers, vascular access ports, injection ports (such as used with gastric banding systems) and gastric pacing devices. Such implants need to be attached, typically subcutaneously, in an appropriate place in order to function properly. It is desirable that the procedure to implant such devices be quick, easy and efficient and require as small of an incision as possible.
The present invention, in one aspect, provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port and a tool for attaching an access port to a patient. The access port may be latched onto an interior portion, or muscle portion of a patient through various methods described herein.
In another aspect of the invention, access ports, or access port assemblies are provided. An access port assembly in accordance with the invention can be used in place of a conventional access port assembly designed to be used for facilitating inflation and deflation of a gastric band.
In yet another aspect of the invention, tools for securing a fluid access port assembly to a patient are provided.
In one embodiment, an access port assembly(is provided which comprises a septum, for example, a self-sealing septum, for receiving a needle, and a plurality of anchor assemblies, spaced apart from the septum. Each of the anchor assemblies is rotatable from a deployed position to an undeployed position. In one embodiment, each of the anchor assemblies is rotatable between a retracted or undeployed position, a midway position and a deployed position.
In one embodiment, each anchor assembly is a composite element. For example, each anchor assembly may be made of at least two different materials. In an exemplary embodiment, the anchor assembly includes a wire portion, for example made of a suitable metal, and a molded portion, for example, made of a polymer material, such as a suitable plastic, fixed to the wire portion.
In one embodiment, each anchor assembly is made of a bioresorbable material. A portion of each anchor assembly, or the entirety of each anchor assembly may be made of one or more bioresorbable materials.
The wire portion may include a curved region and a distal tip structured to penetrate and engage tissue. The molded portion is fixed to the wire portion, or molded to the wire portion. In one embodiment, the molded portion comprises a material which is overmolded to the wire portion. The molded portion may be molded or overmolded to a proximal region of the wire portion.
The molded portion may include a pivot axle substantially perpendicular to the plane of rotation of the wire portion. The molded portion may further comprise an actuator pin and a deploy pin spaced apart from the actuator pin.
In one embodiment, the rotation of an outer housing, or actuator, of the port causes each anchor assembly to rotate from the undeployed position to the deployed position. This may be accomplished by simply rotating the outer housing by hand which causes the anchor assemblies to deploy. Once deployed, there may be an audible “snap” to alert the physician that the anchors are fully deployed.
The anchor assembly and the actuator may be structured such that a torque applied to the anchor assembly increases as the anchor assemblies move from a retracted position to a deployed position.
In another aspect of the invention, an access port assembly is provided which comprises a septum, a housing secured to the septum and include a base substantially opposing the septum. The access port further comprises a plurality of anchors, for example, the anchor assemblies described elsewhere herein. In this particular embodiment, the access port assembly further comprises an attachment member, for example, a mesh member, secured to the base for encouraging tissue ingrowth when the port assembly is implanted in a patient. The mesh member is disposed along at least a portion of the housing and is effective to encourage or promote tissue ingrowth or tissue engagement after the access port assembly has been implanted in the patient.
In one embodiment, the mesh member does not substantially extend beyond the base. In another embodiment, the mesh member includes a portion extending beyond the base. For example, the portion of the mesh may extend outwardly from and substantially circumscribe the base.
Attachment of the mesh material may be accomplished in any suitable manner. For example, a size of mesh can be manually attached to a mesh ring that snaps to the bottom of the port (e.g., the base of the port). Alternatively, the mesh member can be ultrasonically welded to the bottom of a mesh ring that snaps onto the bottom of the port. In addition, the mesh member may be positioned between the mesh ring and the base of the port. Furthermore, the mesh member may be molded or overmolded to the base of the access port to form an integral member with the base. The mesh member may have an oversized shape that allows the mesh to be supplied with the port and cut to the desired size.
In another aspect of the invention, a coating of bioresorbable material may be placed over a portion or the entirety of the base.
In another aspect of the invention, the base of the access port itself may be made of one or more bioresorbable materials.
In another aspect of the invention, a pulpation ring, or locking ring, may be fixed to the access port housing to form a ring-shaped gap. In addition, a compression ring may be placed within the access port housing. A portion of the septum may enter into the ring-shaped gap and be compressed by the pulpation ring and the compression ring, to provide a blocking point to prevent fluid from exiting the access port. The ring-shaped gap may be sized such that a standard syringe needle can not penetrate the septum in the cavity.
In another aspect of the invention, a tool is provided for facilitating attachment of a port, for example, the access port assembly described and shown elsewhere herein, to bodily tissue. In one embodiment, the tool includes a handle having a trigger, and an actuator head structured to removably engage the port housing.
In a particularly advantageous embodiment, the actuator head is rotatable or pivotal with respect to the handle, which facilitates manipulation and positioning of the access port. In one embodiment, the actuator head is rotatable at least 90 degrees and in other embodiments, the actuator head is rotatable up to 180 degrees, or even 360 degrees.
In another aspect of the invention, the actuator head is structured to engage the port assembly in more than one position, or orientation with respect to the actuator head.
These and other aspects of the invention may be more clearly understood and/or appreciated by referring to the accompanying drawings and detailed description.
The present invention relates to implantable medical devices and surgical instruments and fasteners, and more specifically to access ports and tools for applying same to bodily tissue.
As shown in
The gastric band 4 is shown in a deflated state in
Turning now to
The handle 16 couples to the actuator head 18 through a generally cylindrically shaped extension tube 20. The extension tube 20 has a hollow interior cavity that allows a cable assembly 40 to pass from the handle 16 to the actuator cap 42. A proximal portion 32 of the extension tube 20 may have a pivot device 31, or a slotted portion of the extension tube 20 that engages with the handle 16. The pivot device 31 may allow the extension tube 20 to pivot, swivel, or rotate with respect to the handle 16, and allow the actuator head 18 to pivot with respect to the handle 16, as shown in
A distal end 34 of the extension tube 20 couples to the actuator head 18. In the embodiment shown in
The cable assembly 40 connects from the handle 16 to the actuator cap 42. The cable assembly 40 has a proximal portion 44 and a distal portion 46, with stiff, yet flexible, cable 50 extending between the portions 44, 46. The proximal portion 44 includes a ball 47, or a ball head, positioned at the end of the cable 50. The ball 47 engages the trigger 26. The proximal portion 44 may additionally include a sheath 48 that strengthens the proximal portion 44, and is positioned near the ball 47. The sheath 48 generally provides a resistance to damage to the cable 50 during operation of the tool 14. The sheath may be made of stainless steel, or the like. The sheath 48 may additionally constitute an attachment point from the cable 50 to the ball 47.
The cable 50 extends from the proximal portion 44 to the distal portion 46 of the cable assembly 40, and includes an attachment device 52 positioned at the distal portion 46. The attachment device 52 is configured to engage the actuator cap 42, and may include a ball device, a plug device, or the like. The cable 50 is preferably made from a stiff, yet flexible material, such as a threaded metal, nitinol, or the like. The cable 50 is made from a stiff material to allow the cable 50 to transmit both a pulling force and a pushing force to the actuator cap 42 when the tool 14 is operated.
During assembly of the tool 14, the radius tube 36 is installed into the actuator head 18 in the orientation shown in
The extension tube 20 is either threaded into the handle 16, to firmly secure the extension tube 20 in position with respect to the handle 16, or the pivot device 31 is engaged with a mating slot in the handle 26. The mating slot conforms to the shape of the pivot device 31, and will allow the extension tube 20 and actuator head 18 to rotate with respect to the handle 16. The actuator head 18 may rotate with respect to the handle 16 because the extension tube 20 is firmly fixed to the radius tube 36.
The actuator cable assembly 40 is then fed through the top of the handle 16 and into a Teflon tube that has a clearance fit inside the extension tube 20 and continues into the radius tube 36. The Teflon tube reduces friction and improves the tactile feedback to the trigger 26. The cable assembly 40 passes through the radius tube 36 and the distal end 46 of the cable assembly 40 is coupled to the actuator cap 42. More specifically, the attachment device 52 of the cable assembly 40 is fixed to the actuator cap 42 along a slotted groove 54 positioned along the top perimeter of the actuator cap 42. The slotted groove 54 may extend around a portion, or around the entire top surface of the actuator cap 42. The slotted groove 54 allows a slack portion of the cable 50 to wrap around the actuator cap 42 and further increases the total contact surface area between the cable 50 and the actuator cap 42. The increased contact surface area increases the torque strength transmitted from the cable 50 to the actuator cap 42.
The trigger 26 is inserted into the trigger engagement portion 22 in the direction shown by arrow 56. The pins 28 on the trigger 26 engage with the apertures 30, to allow the trigger 26 to rotate with respect to an axis of rotation 60.
When the trigger 26 is inserted into the trigger engagement portion 22, the ball 47 positioned at the proximal end 44 of the cable assembly 40 attaches to the trigger 26. A ball receiving structure 58 of the trigger 26 engages the ball 47 of the cable assembly 40. The ball receiving structure 58 may comprise a cavity to receive the ball 47, or any equivalent structure that retains the ball 47.
The connection between the distal end 46 of the cable 50 and the actuator cap 42 is made by fixing the attachment device 52 to the actuator cap 42, and then wrapping slack in the cable 50 around the outer top surface of the actuator cap 42. The outer top surface of the actuator cap 42 includes the slotted groove 54 along the top of the actuator cap 42. When the cable 50 is wrapped around the outer slotted groove 54 of the actuator cap 42, a smaller boss diameter 62 of the actuator cap 42 is mated with a mating diameter 64 of the actuator head 18. Thus, the actuator cap 42 may rotate with respect to the actuator head 18, through the pivotal connection between the smaller boss diameter 62 and the mating diameter 64. A compression force applied to the actuator cap 42 and the actuator head 18 seats a snap interface and completes assembly of the tool 14.
In operation, when the trigger 26 is pressed in the direction indicated by the arrow 70, the ball receiving structure 58 pulls on the ball 47 of the cable assembly 40. The cable 50 is then pulled in a direction towards the handle 16, which rotates the actuator cap 42. The distal portion 46 of the cable assembly 40, wrapped around the slotted groove 54, assures the translational movement of the cable 50 up or down along inside the interior of the extension tube 20 is converted to a rotational movement of the actuator cap 42. To return the tool 14 to the system shown in
The extension tube 20 may define a lateral axis 72 that the actuator head 18 may rotate around. Depending on the configuration of the tool 14, the actuator head 18 may be configured to rotate 90 degrees about the axis 72, 180 degrees about the axis 72, or 360 degrees about the axis 72. In addition, a friction mechanism or locking mechanism may be used to hold the rotated actuator head 18 in position after it has been rotated. In one embodiment, the friction between the pivot device 31 and the mating slot may be sufficient to hold the actuator head 18 in position after it has been rotated.
The ball 47 located at the proximal end 44 of the cable assembly 40 allows the cable assembly 40 to rotate with the actuator head 18. A shape of a cavity of the ball receiving structure 58 corresponds to the shape of the ball 47 and allows the ball 47 to rotate within the cavity. The ball 47 of the cable assembly 40 therefore aids, or enables the actuator head 18 to pivot with respect to the handle 16.
The actuator head 18 pivots to allow a user to have a rotational degree of freedom when inserting the access port 10 into a patient's body. The rotating actuator head 18 allows the user to insert the access port 10 in multiple positions, yet retain the same grip on the handle 16. This feature may be beneficial if the access port 10 will be attached to a portion of the patient's body that is difficult to access. In general, the rotational feature facilitates greater manipulation and positioning of the access port 10 during implantation.
The housing 90 includes an access port connector 95 at one side of the housing 90. The access port connector 95 is configured to engage a tube 6 connecting from the access port 10 to the gastric band 4 (as shown in
The access port housing 90 generally may define two interior cavities. One interior cavity includes the fluid chamber 106 (shown more clearly in
The access port 10 further comprises a plurality of anchor assemblies 100 (sometimes hereinafter referred to simply as anchor 100). Referring to
In one embodiment, each anchor assembly 100 is made of a bioresorbable material. A portion of the anchor assembly 100 or the entirety of the anchor assembly may be made of one or more bioresorbable material. For example, the wire portion 124, or the molded portion 128, or both, may be made of a bioresorbable material. The bioresorbable material serves to increase the biological compatibility between the anchor 100 and the body tissue.
The wire portion 124 may include a distal portion 120 and a proximal portion 122. The distal portion 120 may include a distal tip 126 structured to penetrate and engage tissue. The distal tip 126 represents the end point of the wire portion 124. The wire portion 124 may have a generally curved shape, to allow the anchor 100 to hook into, and engage the tissue located below the access port 10. In addition, the wire portion 124 may have a generally circular cross section, to reduce friction with the tissue, and to reduce the total cross sectional surface area contacting the tissue. The circular cross section may extend over the length of the wire portion 124, until the wire portion 124 terminates in the distal tip 126. The circular cross section is formed because the wire portion 124 may be considered simply as a curved needle. In addition, the circular, constant cross section may be additionally beneficial if the wire is formed from, for example, stainless steel. The stainless steel wire may be work hardened, giving it a higher strength than wrought material. The circular cross section may therefore comprise an improvement over, for example, an anchor having a tapered shape.
The proximal portion 122 includes the molded portion 128 molded, or overmolded to the proximal portion 122 of the wire portion 124. The molded portion 128 may include a pivot axle 130 with an axis that extends in a direction substantially perpendicular to a plane of rotation of the wire portion 124. Further, the molded portion 128 may comprise an actuator pin 132 also extending in a direction substantially perpendicular to a plane of rotation of the wire portion 124. The actuator pin 132 is spaced apart from the pivot axle 130, preferably at a far, or the furthest distance available on the molded portion 128 from the pivot axle 130. Thus, the actuator pin 132 may be spaced at one end of the molded portion 128 from the pivot axle 130. In addition, the molded portion 128 may comprise a deploy pin 134 extending in a direction substantially perpendicular to a plane of rotation of the wire portion 124.
The deploy pin 134 is spaced apart from the actuator pin 132 and the pivot axle 130. The actuator pin 132 and deploy pin 134 may be formed during the molding process of the molded portion 128, such that they represent a singular, continuous unit with the molded portion 128. In the embodiment shown in
Referring back to
Referring now to
The mesh member 136 may encourage local tissue around the access port 10 to engage with the access port 10 after the access port 10 has been applied. The mesh member 136 aids to secure the access port 10 in place on the patient's tissue. In addition, the mesh member may aid to form a biological seal, or a dermal interface, around the interface between the tissue and the access port 10. In addition, the mesh member 136 may prevent the local tissue from rejecting the access port 10 and may decrease the chance of medical complications related to the access port 10.
Furthermore, a portion of the mesh member 136 may be used as an attachment point to suture, staple, or otherwise lock the access port 10 to the patient's body.
The mesh member 136 may be made of a bioresorbable material, such as silk, or the like, or may be made of a non-resorbable material such as polypropylene, or the like. In addition, the mesh member 136 may be made of a blend of both bioresorbable materials and non-resorbable materials such as a Covidien mesh, or the like.
The mesh member 136 may be used to engage bodily tissue in conjunction with either sutures extending from the suture holes 112 or with use of the anchor assemblies 100, or both. If the anchor assemblies 100 are used to fix the access port 10 to bodily tissue, the mesh member 136 may include apertures 142 appropriately sized to allow a portion of the anchor assemblies 100 to pass through the mesh member 136. In addition, the mesh member 136 may be sized to allow the anchor assemblies 100 to pass through the mesh member 136 without contacting or damaging the mesh member 136. If the mesh member 136 is appropriately sized, no apertures 142 may be needed.
The mesh member 136 may be fixed to the base 92 of the housing 90, through a mesh ring 138, shown more clearly in
The mesh ring 138 may additionally include a plurality of apertures 144 that allow the anchor assemblies 100 to pass through the mesh ring 138 and engage tissue. These apertures 144 may be excluded if the anchor assemblies 100 are not used to fix the access port 10 to the patient. In addition, the mesh ring 138 may include a plurality of columns 140 that engage the base 92 of the housing 90. If the suture holes 112 are not used to engage the access port 10 with bodily tissue, the plurality of columns 140 may engage with the suture holes 112. The plurality of columns 140 may equivalently engage to other portions of the access port housing 90. Other equivalent attachment means may also be used.
The mesh member 136 may be attached to the mesh ring 138 mechanically or by physically wrapping or tying the mesh member 136 to the mesh ring 138. In addition, a latching mechanism may be used to attach the mesh member 136 to the mesh ring 138.
The mesh ring 138 allows the physician, at the time the access port 10 is inserted, to determine whether or not to include the mesh member 136. The detachable mesh ring 138, removably fixed to the base 92, allows a physician to choose whether or not to detach the mesh ring 138. In addition, the mesh ring 138 may provide clearance for bodily tissue to better engage the mesh member 136, by providing more distance between body tissue and the base 92. In one embodiment, the mesh ring 138 may be permanently fixed to the base 92 (e.g., an embodiment where the mesh ring 138 is not detachable from the base 92).
In one embodiment, the mesh member 136 may be integrally molded into or as part of the base 92 of the access port 10. In this embodiment, the mesh member 136 and the base 92, particularly the bottom surface 151 of the base 92, may be molded as one piece. In addition, the mesh member 136 may be overmolded on to the base 92, or a portion of the base 92. The mesh member 136 and base 92 may be made of different materials or the same materials, particularly the materials discussed above in relation to
In one embodiment, the bottom surface 151 of the base 92 may be coated with a bioresorbable material, to encourage biological compatibility between the base 92 and the body tissue.
Similarly, in one embodiment, the base 92 itself (particularly the bottom surface 151 of the base 92), may be made entirely or partially from a bioresorbable material. Thus, a portion of the bottom surface 151 of the base 92 or the entirety of the bottom surface 151 of the base 92 may be made of a bioresorbable material. The bioresorbable base 92 may be formed through a process including a molding process, a forming process, a stamping process, or other equivalent means of forming a base 92 partially or entirely formed of bioresorbable material to the base 92. The bioresorbable base 92, as discussed above in relation to the coating of bioresorbable material, serves to form a biological seal between the access port 10 and the body tissue, and to encourage compatibility between the access port 10 and the body tissue.
During operation, the actuator 108 starts to rotate in a counter-clockwise manner (with respect to the view shown in
In
As shown in
It is beneficial if the torque is at a maximum, or at a near maximum at the position shown in
To retract the anchor assembly 100 shown in
In the exemplary embodiments shown in
Each anchor assembly 100 may be made from stainless steel wire that is bent and sharpened. Wire is an efficient geometry to penetrate tissue, because of the minimal cross section, but it may be difficult to manufacture complex geometry with accurate bends. However, the wire used to form the anchor assemblies 100 requires only two simple bends which can be produced with accuracy due to the simplicity of manufacture.
Additional benefits of the anchor assembly 100 design include a greatly reduced force required to deploy the anchor assemblies 100, and that the anchors 100 do not require precision grinding for ample penetration into tissue. In addition, the design does not require high performance plastics such as PEEK. Furthermore, the manufacturing process is capable of 100% yield, the design does not require tight tolerances, there is a reduced high volume unit cost, the total number of components is low, and all complex parts are injection molded.
This upper rim 113 portion may be compressed between the pulpation ring 110 and the compression ring 107, to provide a tight seal for the fluid chamber 106. The septum 102 may include a top portion 175, a bottom portion 177, and the upper rim 113 portion positioned near the top portion 175. The upper rim 113 portion forms a concentric lip, or extended ridge, extending out further than the outer extent of the bottom portion 177 of the septum 102, or a local top portion 175 of the septum 102 not comprising the upper rim 113 portion. This upper rim 113 portion substantially encircles an outer circumference of the septum 102.
In addition, the pulpation ring 110 may include an inner annular ring portion 174 that extends in a direction towards the center of the top surface 176 of the septum 102. The pulpation ring 110 engages with a portion of the housing 90 including an inner circumference 179. The length of the annular ring portion 174 may be increased, to decrease the incident angle a syringe needle must travel at towards the septum 102, to contact the ring shaped gap 172. If the length of the annular ring portion 174 increases sufficiently, a syringe needle may need to pass nearly horizontally towards the ring shaped gap 172 to breach the compressed septum 102 and cause the fluid chamber 106 to leak. Furthermore, a height 178 of the ring shaped gap 172 may be sufficiently small such that a syringe needle can not penetrate the ring shaped cavity. For example, the height 178 may be smaller than 0.010 inches, leaving a small gap with a size narrower than the diameter of a conventional syringe needle. Thus, a conventional syringe needle could not penetrate the ring shaped gap 172. The ring shaped gap 172 helps to maintain the sealing integrity of the access port 10. The annular ring portion 174, and the ring shaped gap 172, may all have an annular, concentric shape conforming to the shape of the central cavity 104.
The actuator head 18 is configured to mate with the access port. The actuator head 18 generally has a cylindrical shape conforming to a cylindrical shape of the access port 10, and receiving the access port 10. Retaining clips (shown in
In addition, a set of actuator features 180, shown in
The actuator head 18 additionally includes cam protrusions 184, shown in
In the retracted, or undeployed state shown in
The tool 14 can then be reapplied to the access port 10 in either the retracted or deployed state. In the deployed state the actuator head 18 is placed in contact with the access port 10 and the trigger 26 is reversed to its retracted state. This operation retracts the anchor assemblies 100 and the retainer clips 182, which capture the access port 10 for removal. The access port 10 can also be removed by the tool 14 when it is in the retracted state. By pushing the actuator head 18 onto the access port 10 the retainer clips 182 will spring out, allowing the actuator cap 54 to contact the access port actuator 108. Because the actuator features 180 in the actuator cap 42 are not longer aligned with the actuator side cuts 105 in the actuator 108, the retainer clips 182 cannot engage the side cut 114 of the access port 10. However, pulling the trigger 26 to the deployed state will rotate the actuator cap 42 until it aligns with the access port actuator 108. At the end of the trigger pull, the actuator features 180 in the actuator cap 42 will engage the actuator side cuts 105. Reversing the trigger 26 will then retract the anchors 100 and capture the access port 10 for removal.
The terms “a,” “an,” “the” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
Certain embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Specific embodiments disclosed herein may be further limited in the claims using consisting of or and consisting essentially of language. When used in the claims, whether as filed or added per amendment, the transition term “consisting of” excludes any element, step, or ingredient not specified in the claims. The transition term “consisting essentially of” limits the scope of a claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s). Embodiments of the invention so claimed are inherently or expressly described and enabled herein.
In closing, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Accordingly, the present invention is not limited to that precisely as shown and described.
The present Application for Patent claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 61/236,869, filed on Aug. 26, 2009, and U.S. Provisional Patent Application Ser. No. 61/237,641, filed on Aug. 27, 2009, both Applications hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2163048 | McKee | Jun 1939 | A |
2737954 | Knapp | Mar 1956 | A |
3587115 | Shiley | Jun 1971 | A |
3596660 | Melone | Aug 1971 | A |
3667081 | Burger | Jun 1972 | A |
3688764 | Reed | Sep 1972 | A |
3731352 | Okamoto et al. | May 1973 | A |
3840018 | Heifetz | Oct 1974 | A |
3958562 | Hakim et al. | May 1976 | A |
3971376 | Wichterle | Jul 1976 | A |
4019499 | Fitzgerald | Apr 1977 | A |
4118805 | Reimels | Oct 1978 | A |
4151835 | Showell et al. | May 1979 | A |
4161943 | Nogier | Jul 1979 | A |
4164943 | Hill et al. | Aug 1979 | A |
4190040 | Schulte | Feb 1980 | A |
4233992 | Bisping | Nov 1980 | A |
4265252 | Chubbuck et al. | May 1981 | A |
4413985 | Wellner | Nov 1983 | A |
4474572 | McNaughton et al. | Oct 1984 | A |
4502335 | Wamstad et al. | Mar 1985 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4557722 | Harris | Dec 1985 | A |
4569675 | Prosl et al. | Feb 1986 | A |
4588394 | Schulte et al. | May 1986 | A |
4592339 | Kuzmak et al. | Jun 1986 | A |
4592355 | Antebi | Jun 1986 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4655765 | Swift | Apr 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4696288 | Kuzmak et al. | Sep 1987 | A |
4704103 | Stober et al. | Nov 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4738657 | Hancock et al. | Apr 1988 | A |
4767410 | Moden et al. | Aug 1988 | A |
4772270 | Wiita et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4796641 | Mills et al. | Jan 1989 | A |
4802885 | Weeks et al. | Feb 1989 | A |
4832054 | Bark | May 1989 | A |
4840615 | Hancock et al. | Jun 1989 | A |
4850227 | Luettgen et al. | Jul 1989 | A |
4858623 | Bradshaw et al. | Aug 1989 | A |
4861341 | Woodburn | Aug 1989 | A |
4881939 | Newman | Nov 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4902278 | Maget et al. | Feb 1990 | A |
4904241 | Bark | Feb 1990 | A |
4913702 | Yum et al. | Apr 1990 | A |
4915690 | Cone et al. | Apr 1990 | A |
4929230 | Pfleger | May 1990 | A |
4929236 | Sampson | May 1990 | A |
4966588 | Rayman et al. | Oct 1990 | A |
4967755 | Pohndorf | Nov 1990 | A |
4978338 | Melsky et al. | Dec 1990 | A |
5006115 | McDonald | Apr 1991 | A |
5013298 | Moden et al. | May 1991 | A |
5026344 | Dijkstra et al. | Jun 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5074868 | Kuzmak | Dec 1991 | A |
5090954 | Geary | Feb 1992 | A |
5092897 | Forte | Mar 1992 | A |
5094244 | Callahan et al. | Mar 1992 | A |
5108377 | Cone et al. | Apr 1992 | A |
5125408 | Basser | Jun 1992 | A |
5133753 | Bark et al. | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5147483 | Melsky et al. | Sep 1992 | A |
5152747 | Olivier | Oct 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5185003 | Brethauer | Feb 1993 | A |
5207644 | Strecker | May 1993 | A |
5213574 | Tucker | May 1993 | A |
5226429 | Kuzmak | Jul 1993 | A |
5226894 | Haber et al. | Jul 1993 | A |
5250026 | Ehrlich et al. | Oct 1993 | A |
5273537 | Haskvitz et al. | Dec 1993 | A |
5281205 | McPherson | Jan 1994 | A |
5284479 | de Jong | Feb 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5336194 | Polaschegg et al. | Aug 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5368040 | Carney | Nov 1994 | A |
5387192 | Glantz et al. | Feb 1995 | A |
5449368 | Kuzmak | Sep 1995 | A |
5476460 | Montalvo | Dec 1995 | A |
5514174 | Heil, Jr. et al. | May 1996 | A |
5540648 | Yoon | Jul 1996 | A |
5556388 | Johlin, Jr. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5571104 | Li | Nov 1996 | A |
5575777 | Cover et al. | Nov 1996 | A |
5601604 | Vincent | Feb 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5653755 | Ledergerber | Aug 1997 | A |
5658298 | Vincent et al. | Aug 1997 | A |
5674397 | Pawlak et al. | Oct 1997 | A |
5683447 | Bush et al. | Nov 1997 | A |
5688237 | Rozga et al. | Nov 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5716342 | Dumbraveanu et al. | Feb 1998 | A |
5718682 | Tucker | Feb 1998 | A |
5722957 | Steinbach | Mar 1998 | A |
5748200 | Funahashi | May 1998 | A |
5810735 | Halperin et al. | Sep 1998 | A |
5814019 | Steinbach et al. | Sep 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5843033 | Ropiak | Dec 1998 | A |
RE36176 | Kuzmak | Mar 1999 | E |
5883654 | Katsuyama | Mar 1999 | A |
5902598 | Chen et al. | May 1999 | A |
5906596 | Tallarida | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911704 | Humes | Jun 1999 | A |
5931829 | Burbank et al. | Aug 1999 | A |
5932460 | Mills et al. | Aug 1999 | A |
5935083 | Williams | Aug 1999 | A |
5938669 | Klaiber et al. | Aug 1999 | A |
5951512 | Dalton | Sep 1999 | A |
6024704 | Meador et al. | Feb 2000 | A |
6030369 | Engelson et al. | Feb 2000 | A |
6039712 | Fogarty et al. | Mar 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6090066 | Schnell | Jul 2000 | A |
6098405 | Miyata et al. | Aug 2000 | A |
6102678 | Peclat | Aug 2000 | A |
6102922 | Jakobsson et al. | Aug 2000 | A |
6123700 | Mills et al. | Sep 2000 | A |
6152885 | Taepke | Nov 2000 | A |
6171252 | Roberts | Jan 2001 | B1 |
6183449 | Sibbitt | Feb 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6221024 | Miesel | Apr 2001 | B1 |
6234973 | Meador et al. | May 2001 | B1 |
6258079 | Burbank et al. | Jul 2001 | B1 |
6264676 | Gellman et al. | Jul 2001 | B1 |
6283949 | Roorda | Sep 2001 | B1 |
6321124 | Cigaina | Nov 2001 | B1 |
6349740 | Cho et al. | Feb 2002 | B1 |
6432040 | Meah | Aug 2002 | B1 |
6450946 | Forsell | Sep 2002 | B1 |
6453907 | Forsell | Sep 2002 | B1 |
6454699 | Forsell | Sep 2002 | B1 |
6459917 | Gowda et al. | Oct 2002 | B1 |
6461293 | Forsell | Oct 2002 | B1 |
6464628 | Forsell | Oct 2002 | B1 |
6470213 | Alley | Oct 2002 | B1 |
6470892 | Forsell | Oct 2002 | B1 |
6478783 | Moorehead | Nov 2002 | B1 |
6511490 | Robert | Jan 2003 | B2 |
6547801 | Dargent et al. | Apr 2003 | B1 |
6572587 | Lerman et al. | Jun 2003 | B2 |
6589184 | Noren et al. | Jul 2003 | B2 |
6648849 | Tenhuisen et al. | Nov 2003 | B2 |
6666845 | Hooper et al. | Dec 2003 | B2 |
6689100 | Connelly et al. | Feb 2004 | B2 |
6723053 | Ackerman et al. | Apr 2004 | B2 |
6733519 | Lashinski et al. | May 2004 | B2 |
6792309 | Noren | Sep 2004 | B1 |
6810880 | Jennings, Jr. et al. | Nov 2004 | B1 |
6813964 | Clark et al. | Nov 2004 | B1 |
6860857 | Noren et al. | Mar 2005 | B2 |
6915162 | Noren et al. | Jul 2005 | B2 |
6921267 | van Oostrom et al. | Jul 2005 | B2 |
6929631 | Brugger et al. | Aug 2005 | B1 |
6939299 | Petersen et al. | Sep 2005 | B1 |
6953444 | Rosenberg | Oct 2005 | B2 |
6964204 | Clark et al. | Nov 2005 | B2 |
6966875 | Longobardi | Nov 2005 | B1 |
6997914 | Smith et al. | Feb 2006 | B2 |
7017583 | Forsell | Mar 2006 | B2 |
7020531 | Colliou et al. | Mar 2006 | B1 |
7056286 | Ravenscroft et al. | Jun 2006 | B2 |
7063669 | Brawner et al. | Jun 2006 | B2 |
7073387 | Zdeblick et al. | Jul 2006 | B2 |
7082843 | Clark et al. | Aug 2006 | B2 |
7131945 | Fink et al. | Nov 2006 | B2 |
7144400 | Byrum et al. | Dec 2006 | B2 |
7149587 | Wardle et al. | Dec 2006 | B2 |
7191007 | Desai et al. | Mar 2007 | B2 |
7195774 | Carvalho et al. | Mar 2007 | B2 |
7223239 | Schulze | May 2007 | B2 |
7226419 | Lane et al. | Jun 2007 | B2 |
7261003 | McDonald et al. | Aug 2007 | B2 |
7267645 | Anderson et al. | Sep 2007 | B2 |
7282023 | Frering | Oct 2007 | B2 |
7311716 | Byrum | Dec 2007 | B2 |
7311717 | Egle | Dec 2007 | B2 |
7351198 | Byrum et al. | Apr 2008 | B2 |
7351226 | Herskowitz | Apr 2008 | B1 |
7351240 | Hassler, Jr. et al. | Apr 2008 | B2 |
7353747 | Swayze et al. | Apr 2008 | B2 |
7364542 | Jambor et al. | Apr 2008 | B2 |
7367937 | Jambor et al. | May 2008 | B2 |
7374557 | Conlon | May 2008 | B2 |
7374565 | Hassler, Jr. et al. | May 2008 | B2 |
7390294 | Hassler, Jr. | Jun 2008 | B2 |
7413547 | Lichtscheidl et al. | Aug 2008 | B1 |
7416528 | Crawford et al. | Aug 2008 | B2 |
7437951 | McDonald et al. | Oct 2008 | B2 |
7438718 | Milliman et al. | Oct 2008 | B2 |
7445614 | Bunodiere et al. | Nov 2008 | B2 |
7468038 | Ye et al. | Dec 2008 | B2 |
7500944 | Byrum et al. | Mar 2009 | B2 |
7510530 | Hashimoto et al. | Mar 2009 | B2 |
7530943 | Lechner | May 2009 | B2 |
7553298 | Hunt | Jun 2009 | B2 |
7561916 | Hunt | Jul 2009 | B2 |
7580746 | Gilkerson et al. | Aug 2009 | B2 |
7591185 | Mothilal et al. | Sep 2009 | B1 |
7593777 | Gerber | Sep 2009 | B2 |
7634319 | Schneider et al. | Dec 2009 | B2 |
7651483 | Byrum | Jan 2010 | B2 |
7658196 | Ferreri et al. | Feb 2010 | B2 |
7699770 | Hassler, Jr. et al. | Apr 2010 | B2 |
7708722 | Glenn | May 2010 | B2 |
7762998 | Birk et al. | Jul 2010 | B2 |
7762999 | Byrum | Jul 2010 | B2 |
7775215 | Hassler, Jr. et al. | Aug 2010 | B2 |
7775966 | Dlugos et al. | Aug 2010 | B2 |
7811275 | Birk et al. | Oct 2010 | B2 |
7850660 | Uth et al. | Dec 2010 | B2 |
7862546 | Conlon et al. | Jan 2011 | B2 |
7909754 | Hassler, Jr. et al. | Mar 2011 | B2 |
7909804 | Stats | Mar 2011 | B2 |
8007474 | Uth et al. | Aug 2011 | B2 |
20020013545 | Soltanpour et al. | Jan 2002 | A1 |
20020058969 | Noren et al. | May 2002 | A1 |
20020087147 | Hooper et al. | Jul 2002 | A1 |
20020095181 | Beyar | Jul 2002 | A1 |
20020139208 | Yatskov | Oct 2002 | A1 |
20020198548 | Robert | Dec 2002 | A1 |
20030045800 | Noren et al. | Mar 2003 | A1 |
20030045910 | Sorensen et al. | Mar 2003 | A1 |
20030073880 | Polsky et al. | Apr 2003 | A1 |
20030078506 | Noren et al. | Apr 2003 | A1 |
20030139690 | Aebli et al. | Jul 2003 | A1 |
20040064110 | Forsell | Apr 2004 | A1 |
20040065615 | Hooper et al. | Apr 2004 | A1 |
20040068233 | DiMatteo | Apr 2004 | A1 |
20040082908 | Whitehurst et al. | Apr 2004 | A1 |
20040111050 | Smedley et al. | Jun 2004 | A1 |
20040204692 | Eliasen | Oct 2004 | A1 |
20040254536 | Conlon et al. | Dec 2004 | A1 |
20040254537 | Conlon | Dec 2004 | A1 |
20040260229 | Meir | Dec 2004 | A1 |
20040260319 | Egle | Dec 2004 | A1 |
20040267288 | Byrum et al. | Dec 2004 | A1 |
20040267291 | Byrum et al. | Dec 2004 | A1 |
20040267292 | Byrum et al. | Dec 2004 | A1 |
20040267293 | Byrum et al. | Dec 2004 | A1 |
20040267377 | Egle | Dec 2004 | A1 |
20050010177 | Tsai | Jan 2005 | A1 |
20050049578 | Tu et al. | Mar 2005 | A1 |
20050070875 | Kulessa | Mar 2005 | A1 |
20050070937 | Jambor et al. | Mar 2005 | A1 |
20050085778 | Parks | Apr 2005 | A1 |
20050092093 | Kang et al. | May 2005 | A1 |
20050131325 | Chen et al. | Jun 2005 | A1 |
20050131352 | Conlon | Jun 2005 | A1 |
20050131383 | Chen et al. | Jun 2005 | A1 |
20050148956 | Conlon | Jul 2005 | A1 |
20050149143 | Libbus et al. | Jul 2005 | A1 |
20050209573 | Brugger et al. | Sep 2005 | A1 |
20050240155 | Conlon | Oct 2005 | A1 |
20050240156 | Conlon | Oct 2005 | A1 |
20050267500 | Hassler, Jr. et al. | Dec 2005 | A1 |
20050277899 | Conlon | Dec 2005 | A1 |
20050283041 | Egle | Dec 2005 | A1 |
20050283118 | Uth et al. | Dec 2005 | A1 |
20050283119 | Uth | Dec 2005 | A1 |
20060074439 | Garner et al. | Apr 2006 | A1 |
20060122578 | Lord et al. | Jun 2006 | A1 |
20060161186 | Hassler, Jr. et al. | Jul 2006 | A1 |
20060173423 | Conlon | Aug 2006 | A1 |
20060173424 | Conlon | Aug 2006 | A1 |
20060178647 | Stats | Aug 2006 | A1 |
20060178648 | Barron et al. | Aug 2006 | A1 |
20060184141 | Smith et al. | Aug 2006 | A1 |
20060189887 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060189888 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060190039 | Birk et al. | Aug 2006 | A1 |
20060199997 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060211912 | Dlugos et al. | Sep 2006 | A1 |
20060211913 | Dlugos et al. | Sep 2006 | A1 |
20060211914 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060217668 | Schulze et al. | Sep 2006 | A1 |
20060217673 | Schulze | Sep 2006 | A1 |
20060235445 | Birk et al. | Oct 2006 | A1 |
20060235448 | Roslin et al. | Oct 2006 | A1 |
20060247539 | Schugt et al. | Nov 2006 | A1 |
20060266128 | Clark et al. | Nov 2006 | A1 |
20060293625 | Hunt et al. | Dec 2006 | A1 |
20060293626 | Byrum et al. | Dec 2006 | A1 |
20060293627 | Byrum | Dec 2006 | A1 |
20060293628 | Hunt et al. | Dec 2006 | A1 |
20070010790 | Byrum et al. | Jan 2007 | A1 |
20070015954 | Dlugos | Jan 2007 | A1 |
20070015955 | Tsonton | Jan 2007 | A1 |
20070016231 | Jambor et al. | Jan 2007 | A1 |
20070027356 | Ortiz | Feb 2007 | A1 |
20070038255 | Kieval et al. | Feb 2007 | A1 |
20070060959 | Salo et al. | Mar 2007 | A1 |
20070073250 | Schneiter | Mar 2007 | A1 |
20070078391 | Wortley | Apr 2007 | A1 |
20070088336 | Dalton | Apr 2007 | A1 |
20070088391 | McAlexander | Apr 2007 | A1 |
20070129765 | Gilkerson et al. | Jun 2007 | A1 |
20070135758 | Childers et al. | Jun 2007 | A1 |
20070149947 | Byrum | Jun 2007 | A1 |
20070156013 | Birk | Jul 2007 | A1 |
20070158769 | You | Jul 2007 | A1 |
20070161958 | Glenn | Jul 2007 | A1 |
20070167672 | Dlugos et al. | Jul 2007 | A1 |
20070173685 | Jambor et al. | Jul 2007 | A1 |
20070185462 | Byrum | Aug 2007 | A1 |
20070191717 | Rosen et al. | Aug 2007 | A1 |
20070205384 | Kurosawa | Sep 2007 | A1 |
20070208313 | Conlon | Sep 2007 | A1 |
20070213837 | Ferreri et al. | Sep 2007 | A1 |
20070219510 | Zinn et al. | Sep 2007 | A1 |
20070235083 | Dlugos | Oct 2007 | A1 |
20070250086 | Wiley et al. | Oct 2007 | A1 |
20070255165 | Uesugi et al. | Nov 2007 | A1 |
20070255234 | Haase et al. | Nov 2007 | A1 |
20070265666 | Roberts et al. | Nov 2007 | A1 |
20070282196 | Birk et al. | Dec 2007 | A1 |
20070293829 | Conlon et al. | Dec 2007 | A1 |
20080009680 | Hassler, Jr. | Jan 2008 | A1 |
20080015406 | Dlugos et al. | Jan 2008 | A1 |
20080039772 | Chantriaux et al. | Feb 2008 | A1 |
20080058632 | Tai et al. | Mar 2008 | A1 |
20080097496 | Chang et al. | Apr 2008 | A1 |
20080114308 | di Palma et al. | May 2008 | A1 |
20080119798 | Chantriaux et al. | May 2008 | A1 |
20080243093 | Kalpin et al. | Oct 2008 | A1 |
20080249806 | Dlugos et al. | Oct 2008 | A1 |
20080250340 | Dlugos et al. | Oct 2008 | A1 |
20080250341 | Dlugos et al. | Oct 2008 | A1 |
20080255403 | Voegele et al. | Oct 2008 | A1 |
20080255414 | Voegele et al. | Oct 2008 | A1 |
20080255425 | Voegele et al. | Oct 2008 | A1 |
20080255459 | Voegele et al. | Oct 2008 | A1 |
20080255537 | Voegele et al. | Oct 2008 | A1 |
20080281412 | Smith et al. | Nov 2008 | A1 |
20080287969 | Tsonton et al. | Nov 2008 | A1 |
20080287974 | Widenhouse et al. | Nov 2008 | A1 |
20080312553 | Timmons | Dec 2008 | A1 |
20080319435 | Rioux et al. | Dec 2008 | A1 |
20090018608 | Schwartz et al. | Jan 2009 | A1 |
20090048524 | Wildau et al. | Feb 2009 | A1 |
20090054914 | Lechner | Feb 2009 | A1 |
20090062825 | Pool et al. | Mar 2009 | A1 |
20090071258 | Kouda et al. | Mar 2009 | A1 |
20090076466 | Quebbemann et al. | Mar 2009 | A1 |
20090082757 | Rogers et al. | Mar 2009 | A1 |
20090082793 | Birk | Mar 2009 | A1 |
20090093768 | Conlon et al. | Apr 2009 | A1 |
20090099538 | Paganon | Apr 2009 | A1 |
20090105735 | Stam et al. | Apr 2009 | A1 |
20090112308 | Kassem | Apr 2009 | A1 |
20090118572 | Lechner | May 2009 | A1 |
20090149874 | Ortiz et al. | Jun 2009 | A1 |
20090157106 | Marcotte | Jun 2009 | A1 |
20090157107 | Kierath et al. | Jun 2009 | A1 |
20090157113 | Marcotte et al. | Jun 2009 | A1 |
20090171375 | Coe et al. | Jul 2009 | A1 |
20090171378 | Coe et al. | Jul 2009 | A1 |
20090171379 | Coe et al. | Jul 2009 | A1 |
20090192404 | Ortiz et al. | Jul 2009 | A1 |
20090192415 | Ortiz et al. | Jul 2009 | A1 |
20090192533 | Dlugos, Jr. et al. | Jul 2009 | A1 |
20090192534 | Ortiz et al. | Jul 2009 | A1 |
20090192541 | Ortiz et al. | Jul 2009 | A1 |
20090198261 | Schweikert | Aug 2009 | A1 |
20090202387 | Dlugos, Jr. et al. | Aug 2009 | A1 |
20090204131 | Ortiz et al. | Aug 2009 | A1 |
20090204132 | Ortiz et al. | Aug 2009 | A1 |
20090209995 | Byrum et al. | Aug 2009 | A1 |
20090216255 | Coe et al. | Aug 2009 | A1 |
20090221974 | Paganon | Sep 2009 | A1 |
20090222031 | Axelsson | Sep 2009 | A1 |
20090222065 | Dlugos, Jr. et al. | Sep 2009 | A1 |
20090227862 | Smith et al. | Sep 2009 | A1 |
20090228028 | Coe | Sep 2009 | A1 |
20090228072 | Coe et al. | Sep 2009 | A1 |
20090248125 | Brostrom | Oct 2009 | A1 |
20090248126 | Nippoldt et al. | Oct 2009 | A1 |
20090254052 | Birk et al. | Oct 2009 | A1 |
20090259190 | Birk et al. | Oct 2009 | A1 |
20090259191 | Birk et al. | Oct 2009 | A1 |
20090259231 | Birk et al. | Oct 2009 | A1 |
20090264901 | Franklin | Oct 2009 | A1 |
20090299216 | Chen et al. | Dec 2009 | A1 |
20090299672 | Zhang et al. | Dec 2009 | A1 |
20090306462 | Lechner | Dec 2009 | A1 |
20090308169 | Mothilal et al. | Dec 2009 | A1 |
20100087843 | Bertolote et al. | Apr 2010 | A1 |
20100100079 | Berkcan et al. | Apr 2010 | A1 |
20100114149 | Albrecht et al. | May 2010 | A1 |
20100130941 | Conlon et al. | May 2010 | A1 |
20100152532 | Marcotte | Jun 2010 | A1 |
20100191271 | Lau et al. | Jul 2010 | A1 |
20100211085 | Uth et al. | Aug 2010 | A1 |
20100217198 | Franklin et al. | Aug 2010 | A1 |
20100217199 | Uth et al. | Aug 2010 | A1 |
20100217200 | Uth et al. | Aug 2010 | A1 |
20100228080 | Tavori et al. | Sep 2010 | A1 |
20100234808 | Uth et al. | Sep 2010 | A1 |
20110054407 | Olroyd et al. | Mar 2011 | A1 |
20110082426 | Conlon et al. | Apr 2011 | A1 |
20110251453 | Honaryar et al. | Oct 2011 | A1 |
Number | Date | Country |
---|---|---|
1250382 | Apr 2000 | CN |
1367670 | Sep 2002 | CN |
3927001 | Feb 1991 | DE |
4211045 | Oct 1993 | DE |
19751791 | May 1997 | DE |
19745654 | Apr 1999 | DE |
0343910 | Nov 1989 | EP |
0611561 | Sep 1993 | EP |
0858814 | Aug 1998 | EP |
0867197 | Sep 1998 | EP |
1057457 | Dec 2000 | EP |
1346753 | Sep 2003 | EP |
1396242 | Mar 2004 | EP |
1396243 | Mar 2004 | EP |
1488824 | Dec 2004 | EP |
1543861 | Jun 2005 | EP |
1547643 | Jun 2005 | EP |
1591140 | Nov 2005 | EP |
1736194 | Dec 2006 | EP |
1736195 | Dec 2006 | EP |
1736196 | Dec 2006 | EP |
1736197 | Dec 2006 | EP |
1736198 | Dec 2006 | EP |
1736199 | Dec 2006 | EP |
1870126 | Dec 2007 | EP |
1985263 | Oct 2008 | EP |
2070494 | Jun 2009 | EP |
2095798 | Sep 2009 | EP |
2740977 | May 1997 | FR |
2797181 | Feb 2001 | FR |
2823663 | Oct 2002 | FR |
2851168 | Aug 2004 | FR |
2855744 | Dec 2004 | FR |
2916980 | Dec 2008 | FR |
2119877 | May 1990 | JP |
8107934 | Apr 1996 | JP |
1823791 | Jun 1991 | SU |
WO 9422520 | Oct 1994 | WO |
WO 9640357 | Dec 1996 | WO |
WO 9701370 | Jan 1997 | WO |
WO 9920338 | Apr 1999 | WO |
WO 9926543 | Jun 1999 | WO |
WO 9934859 | Jul 1999 | WO |
WO 0015158 | Mar 2000 | WO |
WO 0033901 | Jun 2000 | WO |
WO 0110359 | Feb 2001 | WO |
WO 0149245 | Jul 2001 | WO |
WO 0180926 | Nov 2001 | WO |
WO 0195813 | Dec 2001 | WO |
WO 02074381 | Sep 2002 | WO |
WO 03105732 | Dec 2003 | WO |
WO 2004016971 | Mar 2004 | WO |
WO 2005037055 | Apr 2005 | WO |
WO 2005072627 | Aug 2005 | WO |
WO 2006021695 | Mar 2006 | WO |
WO 2009007526 | Jan 2009 | WO |
WO 2009129474 | Oct 2009 | WO |
Entry |
---|
http://en.wikipedia.org/wiki/Injection—molding. |
Autumn K. et al.; “Evidence of Van Der Waals Adhesion in Gecko Setae”; PNAS; vol. 99; No. 19; pp. 12252-12256; Sep. 17, 2012. |
Geim AK. et al.; “Microfabricated Adhesive Mimicking Gecko Foot-Hair”; Nature Materials Abstract only; vol. 2; No. 7; 2003. |
Yamagami, Takuji; “Technical Developments: Use of Targeting Guide Wire in Left Subclavian Puncture During Percutaneous Implantation of Port-Catheter Systems Using the Catheter Tip Fixation Method” European Radiology; vol. 13; pp. 863-866; 2003. |
Yurdumakan B., et al.; “Synthetic Gecko Foot-Hairs from Multiwalled Carbon Nanotubes”; The Royal Society of Chemistry; p. 3799-3801; 2005. |
Helioscopie Product Insert for Heliogast, pp. 1-11 (undated). |
Number | Date | Country | |
---|---|---|---|
20110054407 A1 | Mar 2011 | US |
Number | Date | Country | |
---|---|---|---|
61263869 | Aug 2009 | US | |
61237641 | Aug 2009 | US |